title: Neuroimmunophilins: a novel drug therapy for the reversal of neurodegenerative disease?
authors.affiliation: Department of Psychology, Neuroscience Research Institute, Carleton University, 1125 Colonel By Drive, Ottawa, Ontario, Canada K1S 5B6. michael_poulter@carleton.ca
authors.forename: M O
authors.initials: MO
authors.lastname: Poulter
authors.forename: K B
authors.initials: KB
authors.lastname: Payne
authors.forename: J P
authors.initials: JP
authors.lastname: Steiner
mesh_terms: D000818:Animals; D002986:Clinical Trials as Topic; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D009410:Nerve Degeneration / Q000188:drug therapy; D019636:Neurodegenerative Diseases / Q000188:drug therapy*; D009474:Neurons / Q000187:drug effects*
chemical_list: D007166:Immunosuppressive Agents